Skip to main content
HANGZHOU AGS MEDTECH CO.,LTD logo

HANGZHOU AGS MEDTECH CO.,LTD — Investor Relations & Filings

Ticker · 688581 ISIN · CNE100005ZF0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2023-08-03 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688581

About HANGZHOU AGS MEDTECH CO.,LTD

http://www.bioags.com/en/index.aspx

Hangzhou AGS MedTech Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical instruments, primarily focusing on endoscopic accessories. The product portfolio encompasses a comprehensive range of disposable devices for gastrointestinal and respiratory interventions, including biopsy forceps, hemoclips, injection needles, polypectomy snares, and guide wires. The company integrates advanced manufacturing processes with rigorous quality management systems, adhering to international standards such as ISO 13485, CE, and FDA. By providing high-precision diagnostic and therapeutic tools, the organization supports clinical procedures in gastroenterology and pulmonology. Its technical expertise facilitates the delivery of reliable solutions aimed at improving procedural outcomes and patient safety in global healthcare markets.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于杭州安杰思医学科技股份有限公司相关股东所持股份延长锁定期的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding the extension of the lock-up period for shares held by certain shareholders of Hangzhou Anjiesi Medical Technology Co., Ltd. It includes legal references, shareholder commitments, shareholding details, and the sponsor's verification opinion. The content focuses on compliance with lock-up commitments post-IPO and does not contain financial statements, earnings data, or management discussion of financial results. It is a regulatory compliance and shareholder lock-up verification report related to IPO shareholding restrictions. This type of document fits best under Regulatory Filings (RNS) as it is a compliance and verification announcement rather than a financial report, management change, or capital update.
2023-08-03 Chinese
关于杭州安杰思医学科技股份有限公司相关股东延长股份锁定期的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Hangzhou Anjiesi Medical Technology Co., Ltd. regarding the extension of the lock-up period for shares held by certain shareholders, including the actual controller, controlling shareholders, and senior management. It details the lock-up commitments, the triggering event (stock price below issuance price for 20 consecutive trading days), and the new lock-up expiration dates. The document includes legal commitments, shareholder names, share quantities, and lock-up period extensions. There is no financial statement, earnings data, or report attached or referenced as being published elsewhere. The content is focused on shareholding restrictions and lock-up period extensions, which is a regulatory announcement related to shareholding and lock-up commitments. This fits best under Regulatory Filings (RNS) as it is a compliance and disclosure announcement that does not fit into other specific categories like Major Shareholding Notification (MRQ) because it is about lock-up period extension rather than shareholding threshold changes, nor is it a Director's Dealing (DIRS) which would be about personal share transactions. Therefore, the classification is Regulatory Filings (RNS).
2023-08-03 Chinese
安杰思2022年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an announcement regarding the implementation of the 2022 annual equity distribution (dividend payment) by the company. It details the dividend per share, relevant dates for record, ex-dividend, and payment, the shareholders' meeting approval date, tax withholding policies, and contact information for inquiries. The document is relatively short (2465 characters) and focuses solely on dividend distribution details without containing financial statements or broader financial performance data. This matches the definition of a Notice of Dividend Amount (DIV) filing, which announces dividend amounts, payment dates, and related shareholder details.
2023-07-13 Chinese
安杰思2022年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2022 Annual General Meeting Resolution Announcement" for Hangzhou Anjiesi Medical Technology Co., Ltd. It details the date and location of the AGM, attendance, voting results on various proposals including financial reports, profit distribution, audit firm reappointment, remuneration plans, and amendments to company articles. It also includes legal witness statements confirming the legality of the meeting and resolutions. The content is focused on the official announcement of the voting results and resolutions passed at the AGM, rather than the full AGM materials or presentations. The document length is about 5572 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation. Therefore, the document fits best into the category of "Declaration of Voting Results & Voting Rights Announcements" (DVA).
2023-06-30 Chinese
北京德恒（杭州）律师事务所关于杭州安杰思医学科技股份有限公司2022年年度股东大会的法律意见
AGM Information Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the legality of the 2022 Annual General Meeting (AGM) of Hangzhou Anjiesi Medical Technology Co., Ltd. It details the procedures of the AGM, attendance, voting process, and results. The document does not contain financial statements or detailed financial performance data but focuses on the legal compliance and validity of the AGM proceedings and resolutions. This matches the description of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. The document length is about 5147 characters, which is sufficient to be the actual legal opinion report rather than a brief announcement. Therefore, the correct classification is AGM Information (AGM-R).
2023-06-30 Chinese
安杰思2022年年度股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as "2022 年年度股东大会会议料" which translates to "2022 Annual General Meeting (AGM) Materials". It contains detailed agenda, reports from the board and supervisory committee, financial reports, and other materials prepared for the 2022 Annual General Meeting. The content includes meeting notices, voting procedures, board work reports, supervisory reports, financial statements, and proposals to be voted on at the AGM. The document is comprehensive and clearly intended as the presentation and materials shared during the AGM, not just an announcement or a brief summary. Therefore, it fits the category of AGM Information (AGM-R).
2023-06-19 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.